1. Home
  2. DFH vs AAPG Comparison

DFH vs AAPG Comparison

Compare DFH & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dream Finders Homes Inc.

DFH

Dream Finders Homes Inc.

HOLD

Current Price

$16.62

Market Cap

1.7B

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$18.47

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFH
AAPG
Founded
2008
2009
Country
United States
China
Employees
N/A
767
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DFH
AAPG
Price
$16.62
$18.47
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$26.00
$48.40
AVG Volume (30 Days)
631.0K
16.4K
Earning Date
05-12-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$4,322,848,000.00
N/A
Revenue This Year
$0.81
$290.34
Revenue Next Year
$7.82
N/A
P/E Ratio
$152.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.20
$16.36
52 Week High
$31.10
$48.45

Technical Indicators

Market Signals
Indicator
DFH
AAPG
Relative Strength Index (RSI) 58.95 52.57
Support Level $13.49 $16.92
Resistance Level $20.26 $25.23
Average True Range (ATR) 1.02 0.48
MACD 0.16 0.31
Stochastic Oscillator 68.85 100.00

Price Performance

Historical Comparison
DFH
AAPG

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc designs, builds and sells homes in markets throughout the United States. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the maximum of its revenue from the Midwest segment.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: